EQT Acquires Mabtech from IK Partners and Mérieux Equity Partners

IK Investment Partners Acquires Mabtech

December 5, 2019

Biotechnology

IK Investment Partners’ IK Small Cap II Fund has agreed to acquire a majority stake in Mabtech AB, a Stockholm-based specialist in immune monitoring and developer of monoclonal antibodies, ELISpot/FluoroSpot kits and the IRIS reader. Mérieux Equity Partners takes a minority stake alongside IK, founders and management remain invested, and EQT Credit provided senior secured (unitranche) financing to support the transaction.

EQT Acquires Majority Stake in Ellab from IK Investment Partners

August 7, 2019

Medical Devices

EQT Mid Market Europe has agreed to acquire a majority interest in Ellab A/S from the IK VIII Fund (advised by IK Investment Partners). EQT will partner with Ellab's management, which will retain a minority stake, to accelerate global growth by expanding R&D, enhancing the go-to-market model in the US and Europe, and growing the company's as-a-service offerings.

EQT Private Equity Acquires SPT Labtech from Battery Ventures for GBP 650 million

June 22, 2022

Medical Devices

EQT Private Equity (EQT IX) has agreed to acquire SPT Labtech, a UK-based designer and manufacturer of automated liquid handling, sample preparation and consumables for life science research, from Battery Ventures for GBP 650 million. EQT will support SPT's next phase of growth by accelerating product innovation, scaling its Cryo-EM sample preparation business and expanding into new geographies and end markets; the transaction is expected to close in Q3 2022.

EQT Invests in MHC Asia Holdings (Healthcare Benefits Administrator)

April 1, 2019

Healthcare Services

EQT Mid Market Asia III Fund has made a strategic investment in MHC Asia Holdings Pte. Ltd., a Singapore-headquartered healthcare benefits administrator serving insurers and corporate clients across Southeast Asia. The investment will support MHC's regional expansion, further development of its technology and analytics capabilities, and growth of its client portfolio.

Discovery Life Sciences Acquires QualTek Molecular Laboratories

May 5, 2019

Healthcare Services

Discovery Life Sciences (based in Huntsville, Alabama) has acquired QualTek Molecular Laboratories, a provider of CAP/CLIA-accredited and GLP-capable immunohistochemistry (IHC) laboratories in California and Pennsylvania. The acquisition expands Discovery's histopathology and IHC assay development capabilities and integrates QualTek's services with Discovery's biospecimen, sequencing, flow cytometry and multiomic annotation offerings to accelerate biomarker validation and drug/diagnostic development.

IK Partners' IK SC III Fund to acquire Tecomatic from PEQ Invest

March 6, 2025

Environmental Services

IK Partners, via its IK Small Cap III (IK SC III) Fund, has signed an agreement to acquire Tecomatic from PEQ Invest. Financial terms were not disclosed; the management team will reinvest and completion is subject to regulatory approval. IK will invest from its Development Capital pool to support Tecomatic's growth and further consolidate its position in the Nordics across water treatment and erosion control solutions.